SCHEMBL3285187

SCHEMBL3285187

Clc1ccc2c(c1)[C@@H](N1CCNCC1)Cn1cccc1S2

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 1/20 0.76
TP53 P04637 2/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
AVPR1A P37288 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
DRD2 P14416 3/20 0.44
HRH1 P35367 3/20 0.44
DRD4 P21917 2/20 0.44
HTR2C P28335 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
NFKB1 P19838 1/20 0.44
CYP2C19 P33261 1/20 0.44
THPO P40225 1/20 0.44
HIF1A Q16665 1/20 0.44
NPC1 O15118 1/20 0.44
MTOR P42345 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3286314 1.00 SLC6A3 (0.76) SLC6A3TP53MAPTMAPK1AVPR1A
SCHEMBL3284872 1.00 SLC6A3 (0.76) SLC6A3TP53MAPTMAPK1AVPR1A
Hydrochloric Acid SCHEMBL3288153 0.99 SLC6A3 (0.74) SLC6A3TP53MAPTMAPK1AVPR1A
Hydrochloric Acid SCHEMBL3288148 0.99 SLC6A3 (0.74) SLC6A3TP53MAPTMAPK1AVPR1A
SCHEMBL30978858 0.86 SLC6A3 (1.00) SLC6A3TP53DRD2HRH1DRD4
SCHEMBL3285100 0.86 SLC6A3 (0.56) SLC6A3TP53MAPTMAPK1AVPR1A
SCHEMBL3285765 0.86 SLC6A3 (1.00) SLC6A3TP53DRD2HRH1DRD4
SCHEMBL3284936 0.85 SLC6A3 (0.54) SLC6A3TP53MAPTMAPK1AVPR1A
SCHEMBL7498755 0.76 SLC6A3 (0.61) SLC6A3TP53DRD2HRH1DRD4
SCHEMBL7544150 0.76 SLC6A3 (0.61) SLC6A3TP53DRD2HRH1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7713956-B2 Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2010-05-11 US claimed
EP-1745054-B1 DEALKYLATED DERIVATIVES OF PYRROLO(2,1-B)BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA TAU IND FARMACEUTI (IT) 2008-11-19 EP claimed
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2007-11-22 US claimed
EP-1745054-A2 DEALKYLATED DERIVATIVES OF PYRROLO(2,1-B)BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. (IT) 2007-01-24 EP claimed
WO-2005108403-A2 DEALKYLATED DERIVATIVES OF PYRROLO[2,1-B]BENZOTHIAZEPINES WITH ATYPICAL ANTIPSYCHOTIC ACTIVITY SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2005-11-17 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270402-A1 Dealkylated Derivatives of Pyrrolo[2,1-B]Benzothiazepines with Atypical Antipsy-Chotic Activity CNR1, HRH4, CNR2 SLC6A3 405/4885TP53 4800/4885MAPT 3163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.